UPDATED Apr 24, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GIG | kr34.10 | -1.7% | 24.0% | kr4.4b | kr49.20 | PE28x | E39.8% | n/a | Consumer Services | ||
523694 | ₹452.55 | -3.0% | -16.6% | ₹23.8b | ₹553.50 | PE38x | E46.9% | 1.2% | Materials | ||
NEWBRY | kr3.39 | -3.1% | -39.0% | kr82.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
517522 | ₹638.45 | -5.2% | -17.3% | ₹32.4b | ₹799.50 | PE45.1x | E35.6% | 0.3% | Materials | ||
HHR | AU$0.007 | -12.5% | -79.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
YGG | ฿7.05 | -11.3% | -0.7% | ฿4.2b | ฿10.75 | PE61.1x | E34.7% | 3.8% | Media | ||
IRISDOREME | ₹79.05 | -0.2% | 11.0% | ₹6.4b | ₹101.00 | PE58.9x | E51.4% | n/a | Consumer Durables | ||
A108860 | ₩16,630.00 | 2.6% | -16.6% | ₩447.6b | n/a | PS8.4x | E98.9% | n/a | Software | ||
NVG | zł2.14 | -11.6% | 39.4% | zł74.9m | zł3.71 | PE7.7x | E28.5% | n/a | Diversified Financials | ||
FDE | €34.40 | 7.5% | 1.2% | €179.9m | €64.07 | PE22.9x | E32.3% | n/a | Energy | ||
FWRY | ج.م6.10 | -21.3% | 4.5% | ج.م20.8b | ج.م7.20 | PE33.6x | E34.8% | n/a | Diversified Financials | ||
ELABS | kr16.90 | 21.4% | 42.0% | kr1.8b | kr25.00 | PS25.9x | E124.6% | n/a | Software | ||
NOHAL | kr22.20 | -3.5% | -7.5% | kr868.2m | kr32.50 | PS8.5x | E56.0% | n/a | Food, Beverage & Tobacco | ||
WAYS | kr22.35 | -4.9% | -58.3% | kr180.4m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
ZVRA | US$4.56 | -1.7% | -12.0% | US$191.7m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.66 | 0.3% | 105.9% | €132.6m | €12.75 | PE27x | E22.8% | n/a | Capital Goods | ||
GWIND | ₺26.50 | 3.8% | 67.8% | ₺14.3b | ₺39.79 | PE22.9x | E60.9% | 1.7% | Utilities | ||
CALTX | kr100.40 | -0.5% | -18.7% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
ATAKP | ₺47.26 | 2.8% | n/a | ₺6.6b | ₺67.66 | PE22.2x | E72.8% | n/a | Food, Beverage & Tobacco | ||
RDUE | €9.50 | 0% | 3.9% | €59.4m | €10.50 | PE17.5x | E37.7% | n/a | Capital Goods | ||
GTHX | US$3.99 | -6.8% | 62.2% | US$218.7m | US$8.50 | PS2.5x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.57 | -8.6% | -39.2% | US$231.7m | US$26.06 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
APLT | US$4.31 | -10.8% | 183.6% | US$509.5m | US$11.60 | PS49.3x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
OSE | €5.64 | 15.7% | 34.3% | €121.6m | €7.15 | PS54.6x | E92.9% | n/a | Pharmaceuticals & Biotech |